Folate, vitamin B12, and homocysteine in major depressive disorder
- PMID: 9054796
- DOI: 10.1176/ajp.154.3.426
Folate, vitamin B12, and homocysteine in major depressive disorder
Abstract
Objective: The authors examined the relationships between levels of three metabolites (folate, vitamin B12, and homocysteine) and both depressive subtype and response to fluoxetine treatment in depressed patients.
Method: Fluoxetine, 20 mg/day for 8 weeks, was given to 213 outpatients with major depressive disorder. At baseline, depressive subtypes were assessed, and a blood sample was collected from each patient. Serum metabolite levels were assayed. Response to treatment was determined by percentage change in score on the 17-item Hamilton Depression Rating Scale.
Results: Subjects with low folate levels were more likely to have melancholic depression and were significantly less likely to respond to fluoxetine. Homocysteine and B12 levels were not associated with depressive subtype or treatment response.
Conclusions: Overall, the results are consistent with findings linking low folate levels to poorer response to antidepressant treatment. Folate levels might be considered in the evaluation of depressed patients who do not respond to antidepressant treatment.
Similar articles
-
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression.J Clin Psychiatry. 2004 Aug;65(8):1090-5. doi: 10.4088/jcp.v65n0810. J Clin Psychiatry. 2004. PMID: 15323594 Clinical Trial.
-
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy.J Clin Psychiatry. 2004 Aug;65(8):1096-8. doi: 10.4088/jcp.v65n0811. J Clin Psychiatry. 2004. PMID: 15323595 Clinical Trial.
-
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine.Int J Neuropsychopharmacol. 2005 Dec;8(4):523-8. doi: 10.1017/S1461145705005195. Epub 2005 May 9. Int J Neuropsychopharmacol. 2005. PMID: 15877935 Clinical Trial.
-
Treatment of depression: time to consider folic acid and vitamin B12.J Psychopharmacol. 2005 Jan;19(1):59-65. doi: 10.1177/0269881105048899. J Psychopharmacol. 2005. PMID: 15671130 Review.
-
[Optimal use of markers for cobalamin/folate status. Results from a survey in a group of psychogeriatric patients].Lakartidningen. 2003 Oct 2;100(40):3136-40. Lakartidningen. 2003. PMID: 14579665 Review. Swedish.
Cited by
-
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Epub 2013 May 3. Neuroscience. 2013. PMID: 23644052 Free PMC article. Review.
-
The sex-specific role of plasma folate in mediating the association of dietary quality with depressive symptoms.J Nutr. 2010 Feb;140(2):338-47. doi: 10.3945/jn.109.113878. Epub 2009 Dec 23. J Nutr. 2010. PMID: 20032481 Free PMC article.
-
Multivitamin supplementation in HIV-positive pregnant women: impact on depression and quality of life in a resource-poor setting.HIV Med. 2007 May;8(4):203-12. doi: 10.1111/j.1468-1293.2007.00454.x. HIV Med. 2007. PMID: 17461847 Free PMC article. Clinical Trial.
-
High vitamin B12 level and good treatment outcome may be associated in major depressive disorder.BMC Psychiatry. 2003 Dec 2;3:17. doi: 10.1186/1471-244X-3-17. BMC Psychiatry. 2003. PMID: 14641930 Free PMC article.
-
The role of vitamins and minerals in psychiatry.Integr Med Insights. 2008;3:33-42. Epub 2008 Sep 24. Integr Med Insights. 2008. PMID: 21614157 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
